PDF) Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison
The European Multidisciplinary Cancer Congress (ECCO 16, ESMO 36 and ESTRO 30)
5-fluorouracil combined with the pure /-stereoisomer of leukovorin calcium to treat advanced colon cancer patients: a phase-II s
Intervista Prof. Camillo Porta - YouTube
PDF) Targeting PI3K/Akt/mTOR signaling in cancer
PDF) Sunitinib in the treatment of renal cell carcinoma: An update on recent evidence
5-Methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo?
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download
PDF) RETRACTION: Challenges of Combined Everolimus/Endocrine Therapy in Hormone Receptor-Positive Metastatic Breast Cancer
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapyâ•'resistant advanced renal cell carcinoma
Camillo Porta, MD
Adjuvant therapies for RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia. - ppt download
PPT - HOW TO SELECT AMONG AVAILABLE OPTIONS FOR THE TREATMENT OF ADVANCED RCC: PowerPoint Presentation - ID:2655374
Prof. Camillo Porta – Epidemiologia del Carcinoma Renale a Cellule Chiare - YouTube
Policlinico Bari, prof. Porta nuovo ordinario di Oncologia - La Gazzetta del Mezzogiorno
Metastatic Clear Cell Renal Cell Carcinoma What Is the Best Sequence in A Multi Line Setting IPSEN
Camillo Porta - insalutenews.it
Video Latest - ecancer
Ferrata Storti Foundation
Tolerability of first-line therapy for metastatic renal cell carcinoma
Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Revie
INTEGRAZIONE TRA TERAPIA CHIRURGICA E TERAPIA MEDICA” Camillo Porta, MD Medical Oncology I.R.C.C.S. San Matteo University Hospital Foundation, Pavia. - ppt download
Recent advances in the frontline treatment of metastatic renal cell carcinoma
Dr. Camillo Porta S.C. di Oncologia Medica, I.R.C.C.S. Fondazione Policlinico San Matteo, Pavia. - ppt download
